{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [],
   "source": [
    "import os\n",
    "import re \n",
    "import pandas as pd\n",
    "import numpy as np\n",
    "\n",
    "from typing import List, Union, Tuple\n",
    "from tqdm.auto import tqdm\n",
    "tqdm.pandas()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {},
   "outputs": [],
   "source": [
    "from dotenv import load_dotenv\n",
    "load_dotenv()\n",
    "\n",
    "OPENAI_API_KEY=os.environ[\"OPENAI_API_KEY\"]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "from pgvector.sqlalchemy import Vector\n",
    "from sentence_transformers import SentenceTransformer\n",
    "from sqlalchemy import create_engine, insert, select, text, Integer, String, Text\n",
    "from sqlalchemy.orm import declarative_base, mapped_column, Session\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [],
   "source": [
    "username = os.environ[\"USERNAME\"]\n",
    "password = os.environ[\"PASSWORD\"]\n",
    "hostname = os.environ[\"HOSTNAME\"]\n",
    "database = \"embedding\"\n",
    "# database = os.environ[\"DATABASE\"]\n",
    "port = os.environ[\"PORT\"]\n",
    "\n",
    "db_credentials = f\"postgresql://{username}:{password}@{hostname}:{port}/{database}\"\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 5,
   "metadata": {},
   "outputs": [],
   "source": [
    "engine = create_engine(db_credentials)\n",
    "with engine.connect() as conn:\n",
    "    conn.execute(text('CREATE EXTENSION IF NOT EXISTS vector'))\n",
    "    conn.commit()\n",
    "\n",
    "Base = declarative_base()\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 6,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>brief_title</th>\n",
       "      <th>official_title</th>\n",
       "      <th>overall_status</th>\n",
       "      <th>baseline_measurements</th>\n",
       "      <th>brief_summaries</th>\n",
       "      <th>detailed_descriptions</th>\n",
       "      <th>criteria</th>\n",
       "      <th>gender</th>\n",
       "      <th>minimum_age</th>\n",
       "      <th>maximum_age</th>\n",
       "      <th>facilities</th>\n",
       "      <th>city</th>\n",
       "      <th>state</th>\n",
       "      <th>zip</th>\n",
       "      <th>country</th>\n",
       "      <th>recruitment_details</th>\n",
       "      <th>pre_assignment_details</th>\n",
       "      <th>study_type</th>\n",
       "      <th>embeddings</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>nct_id</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>NCT00000143</th>\n",
       "      <td>Studies of Ocular Complications of AIDS (SOCA)...</td>\n",
       "      <td>Studies of Ocular Complications of AIDS (SOCA)...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>NaN</td>\n",
       "      <td>To compare the newest CMV retinitis drug, cido...</td>\n",
       "      <td>Cytomegalovirus (CMV) is among the most freque...</td>\n",
       "      <td>Inclusion criteria:\\n\\nAge 13 years or older\\n...</td>\n",
       "      <td>All</td>\n",
       "      <td>13 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>University of South Florida, MDC Box 21</td>\n",
       "      <td>Tampa</td>\n",
       "      <td>Texas</td>\n",
       "      <td>94143</td>\n",
       "      <td>United States</td>\n",
       "      <td>June 1997</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>[-0.010117053490566939, 0.0014353180923144734,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00000378</th>\n",
       "      <td>Antidepressant Treatment of Melancholia in Lat...</td>\n",
       "      <td>Antidepressant Treatment of Melancholia in Lat...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The purpose of this study is to compare the sa...</td>\n",
       "      <td>To compare the efficacy and safety of a select...</td>\n",
       "      <td>Inclusion Criteria:\\n\\n-\\n\\nPatients must have...</td>\n",
       "      <td>All</td>\n",
       "      <td>60 Years</td>\n",
       "      <td>95 Years</td>\n",
       "      <td>1051 Riverside Drive</td>\n",
       "      <td>New York</td>\n",
       "      <td>New York</td>\n",
       "      <td>10032</td>\n",
       "      <td>United States</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>[-0.013839153437317241, -0.003807755615505691,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00000620</th>\n",
       "      <td>Action to Control Cardiovascular Risk in Diabe...</td>\n",
       "      <td>Action to Control Cardiovascular Risk in Diabe...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The purpose of this study is to prevent major ...</td>\n",
       "      <td>BACKGROUND:\\n\\nCurrently, about 17 million Ame...</td>\n",
       "      <td>Inclusion Criteria:\\n\\nDiagnosed with type 2 d...</td>\n",
       "      <td>All</td>\n",
       "      <td>40 Years</td>\n",
       "      <td>79 Years</td>\n",
       "      <td>Wake Forest University</td>\n",
       "      <td>Winston-Salem</td>\n",
       "      <td>Washington</td>\n",
       "      <td>98195</td>\n",
       "      <td>United States</td>\n",
       "      <td>All participants had established type 2 diabet...</td>\n",
       "      <td>Eligible participants provided evidence of abi...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>[-0.02645666465910675, -0.02204721930749222, 0...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00001213</th>\n",
       "      <td>Cysteamine Eye Drops to Treat Corneal Crystals...</td>\n",
       "      <td>Trial of Topical Cysteamine in the Treatment o...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Although 328 participants were initially enrol...</td>\n",
       "      <td>Cystinosis is an inherited disease that result...</td>\n",
       "      <td>Protocol 86-EI-0062 began as a randomized, dou...</td>\n",
       "      <td>INCLUSION CRITERIA:\\n\\nPatients must have a do...</td>\n",
       "      <td>All</td>\n",
       "      <td>2 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>National Institutes of Health Clinical Center,...</td>\n",
       "      <td>Bethesda</td>\n",
       "      <td>Maryland</td>\n",
       "      <td>20892</td>\n",
       "      <td>United States</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>[0.0028949422587708743, -0.016361670996559528,...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT00001259</th>\n",
       "      <td>A Treatment Study for Premenstrual Syndrome (PMS)</td>\n",
       "      <td>The Treatment of Menstrually-Related Mood Diso...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>NaN</td>\n",
       "      <td>This study examines the effects of estrogen an...</td>\n",
       "      <td>This protocol is designed to accompany Clinica...</td>\n",
       "      <td>INCLUSION CRITERIA:\\n\\nThe subjects of this st...</td>\n",
       "      <td>Female</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>45 Years</td>\n",
       "      <td>National Institutes of Health Clinical Center,...</td>\n",
       "      <td>Bethesda</td>\n",
       "      <td>Maryland</td>\n",
       "      <td>20892</td>\n",
       "      <td>United States</td>\n",
       "      <td>One participant signed consent but withdrew pr...</td>\n",
       "      <td>8 of 46 participants who completed Study 2, Ph...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>[-0.040142119659849006, 0.001966558432531476, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT05451225</th>\n",
       "      <td>Survey of Correction Officers Before and After...</td>\n",
       "      <td>Reducing Duration of Untreated Psychosis Throu...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The investigators will implement a multifacete...</td>\n",
       "      <td>Because Correction Officers in the three jails...</td>\n",
       "      <td>Inclusion Criteria:\\n\\nCorrection Officers;\\no...</td>\n",
       "      <td>All</td>\n",
       "      <td>21 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Columbia University</td>\n",
       "      <td>New York</td>\n",
       "      <td>New York</td>\n",
       "      <td>10027</td>\n",
       "      <td>United States</td>\n",
       "      <td>Recruitment of the study sample took place in ...</td>\n",
       "      <td>Correction officers (COs) were recruited at ea...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>[-0.02336861067497135, -0.01617507119686338, 0...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT05489146</th>\n",
       "      <td>t-RNS After Hand Recovery in Chronic Stroke</td>\n",
       "      <td>Combining Transcranial Random Noise Stimulatio...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>Fugl Meyer Upper Extremity Assessment (FMUE) m...</td>\n",
       "      <td>Upper extremity (UE) paresis or weakness is on...</td>\n",
       "      <td>The primary purpose of this study was to inves...</td>\n",
       "      <td>Inclusion Criteria:\\n\\nAge 18 or older\\nEpisod...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>80 Years</td>\n",
       "      <td>Neuromotor Recovery and Rehabilitation Lab</td>\n",
       "      <td>Pittsburgh</td>\n",
       "      <td>Pennsylvania</td>\n",
       "      <td>15260</td>\n",
       "      <td>United States</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>[-0.04131284136615776, 0.0042052526653315984, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT05502081</th>\n",
       "      <td>Clinical Study to Compare Efficacy and Safety ...</td>\n",
       "      <td>Clinical Study to Evaluate the Possible Effica...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>0. Uninfected\\n\\nAmbulatory mild disease\\n\\nAs...</td>\n",
       "      <td>Introduction:\\n\\nCorona Virus induced disease ...</td>\n",
       "      <td>I. INTRODUCTION\\n\\n1.1. COVID-19 overview and ...</td>\n",
       "      <td>Inclusion Criteria:\\n\\nage more than 12 years ...</td>\n",
       "      <td>All</td>\n",
       "      <td>12 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>El-gomhoria St</td>\n",
       "      <td>Mansoura</td>\n",
       "      <td>El-dkhalia</td>\n",
       "      <td>050</td>\n",
       "      <td>Egypt</td>\n",
       "      <td>from 1/11/2021 to 29/5/2022 at isolation hospi...</td>\n",
       "      <td>assignment is applied after admission of parti...</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>[-0.027679480103407456, 0.011526332956244322, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT05594173</th>\n",
       "      <td>Chewing and Oral Processing of Solid Food</td>\n",
       "      <td>Chewing and Oral Processing of Solid Food in H...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Food texture modification is commonly used as ...</td>\n",
       "      <td>Aim: To explore chewing and oral processing be...</td>\n",
       "      <td>Inclusion Criteria:\\n\\nHealthy adults under ag...</td>\n",
       "      <td>All</td>\n",
       "      <td>18 Years</td>\n",
       "      <td>60 Years</td>\n",
       "      <td>Toronto Rehabilitation Institute - University ...</td>\n",
       "      <td>Toronto</td>\n",
       "      <td>Ontario</td>\n",
       "      <td>M5G 2A2</td>\n",
       "      <td>Canada</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Observational</td>\n",
       "      <td>[-0.0020168373226194113, 0.01569151381516552, ...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>NCT05736861</th>\n",
       "      <td>ACTIV-6: COVID-19 Study of Repurposed Medicati...</td>\n",
       "      <td>ACTIV-6: COVID-19 Outpatient Randomized Trial ...</td>\n",
       "      <td>Completed</td>\n",
       "      <td>NaN</td>\n",
       "      <td>The purpose of this study is to evaluate the e...</td>\n",
       "      <td>Severe acute respiratory syndrome coronavirus ...</td>\n",
       "      <td>Inclusion Criteria:\\n\\nCompleted Informed Cons...</td>\n",
       "      <td>All</td>\n",
       "      <td>30 Years</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Well Pharma Medical Research</td>\n",
       "      <td>Yonkers</td>\n",
       "      <td>Virginia</td>\n",
       "      <td>94304</td>\n",
       "      <td>United States</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>Interventional</td>\n",
       "      <td>[-0.02718752011814748, 0.0010122289920352244, ...</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>28623 rows Ã— 19 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                   brief_title  \\\n",
       "nct_id                                                           \n",
       "NCT00000143  Studies of Ocular Complications of AIDS (SOCA)...   \n",
       "NCT00000378  Antidepressant Treatment of Melancholia in Lat...   \n",
       "NCT00000620  Action to Control Cardiovascular Risk in Diabe...   \n",
       "NCT00001213  Cysteamine Eye Drops to Treat Corneal Crystals...   \n",
       "NCT00001259  A Treatment Study for Premenstrual Syndrome (PMS)   \n",
       "...                                                        ...   \n",
       "NCT05451225  Survey of Correction Officers Before and After...   \n",
       "NCT05489146        t-RNS After Hand Recovery in Chronic Stroke   \n",
       "NCT05502081  Clinical Study to Compare Efficacy and Safety ...   \n",
       "NCT05594173          Chewing and Oral Processing of Solid Food   \n",
       "NCT05736861  ACTIV-6: COVID-19 Study of Repurposed Medicati...   \n",
       "\n",
       "                                                official_title overall_status  \\\n",
       "nct_id                                                                          \n",
       "NCT00000143  Studies of Ocular Complications of AIDS (SOCA)...      Completed   \n",
       "NCT00000378  Antidepressant Treatment of Melancholia in Lat...      Completed   \n",
       "NCT00000620  Action to Control Cardiovascular Risk in Diabe...      Completed   \n",
       "NCT00001213  Trial of Topical Cysteamine in the Treatment o...      Completed   \n",
       "NCT00001259  The Treatment of Menstrually-Related Mood Diso...      Completed   \n",
       "...                                                        ...            ...   \n",
       "NCT05451225  Reducing Duration of Untreated Psychosis Throu...      Completed   \n",
       "NCT05489146  Combining Transcranial Random Noise Stimulatio...      Completed   \n",
       "NCT05502081  Clinical Study to Evaluate the Possible Effica...      Completed   \n",
       "NCT05594173  Chewing and Oral Processing of Solid Food in H...      Completed   \n",
       "NCT05736861  ACTIV-6: COVID-19 Outpatient Randomized Trial ...      Completed   \n",
       "\n",
       "                                         baseline_measurements  \\\n",
       "nct_id                                                           \n",
       "NCT00000143                                                NaN   \n",
       "NCT00000378                                                NaN   \n",
       "NCT00000620                                                NaN   \n",
       "NCT00001213  Although 328 participants were initially enrol...   \n",
       "NCT00001259                                                NaN   \n",
       "...                                                        ...   \n",
       "NCT05451225                                                NaN   \n",
       "NCT05489146  Fugl Meyer Upper Extremity Assessment (FMUE) m...   \n",
       "NCT05502081  0. Uninfected\\n\\nAmbulatory mild disease\\n\\nAs...   \n",
       "NCT05594173                                                NaN   \n",
       "NCT05736861                                                NaN   \n",
       "\n",
       "                                               brief_summaries  \\\n",
       "nct_id                                                           \n",
       "NCT00000143  To compare the newest CMV retinitis drug, cido...   \n",
       "NCT00000378  The purpose of this study is to compare the sa...   \n",
       "NCT00000620  The purpose of this study is to prevent major ...   \n",
       "NCT00001213  Cystinosis is an inherited disease that result...   \n",
       "NCT00001259  This study examines the effects of estrogen an...   \n",
       "...                                                        ...   \n",
       "NCT05451225  The investigators will implement a multifacete...   \n",
       "NCT05489146  Upper extremity (UE) paresis or weakness is on...   \n",
       "NCT05502081  Introduction:\\n\\nCorona Virus induced disease ...   \n",
       "NCT05594173  Food texture modification is commonly used as ...   \n",
       "NCT05736861  The purpose of this study is to evaluate the e...   \n",
       "\n",
       "                                         detailed_descriptions  \\\n",
       "nct_id                                                           \n",
       "NCT00000143  Cytomegalovirus (CMV) is among the most freque...   \n",
       "NCT00000378  To compare the efficacy and safety of a select...   \n",
       "NCT00000620  BACKGROUND:\\n\\nCurrently, about 17 million Ame...   \n",
       "NCT00001213  Protocol 86-EI-0062 began as a randomized, dou...   \n",
       "NCT00001259  This protocol is designed to accompany Clinica...   \n",
       "...                                                        ...   \n",
       "NCT05451225  Because Correction Officers in the three jails...   \n",
       "NCT05489146  The primary purpose of this study was to inves...   \n",
       "NCT05502081  I. INTRODUCTION\\n\\n1.1. COVID-19 overview and ...   \n",
       "NCT05594173  Aim: To explore chewing and oral processing be...   \n",
       "NCT05736861  Severe acute respiratory syndrome coronavirus ...   \n",
       "\n",
       "                                                      criteria  gender  \\\n",
       "nct_id                                                                   \n",
       "NCT00000143  Inclusion criteria:\\n\\nAge 13 years or older\\n...     All   \n",
       "NCT00000378  Inclusion Criteria:\\n\\n-\\n\\nPatients must have...     All   \n",
       "NCT00000620  Inclusion Criteria:\\n\\nDiagnosed with type 2 d...     All   \n",
       "NCT00001213  INCLUSION CRITERIA:\\n\\nPatients must have a do...     All   \n",
       "NCT00001259  INCLUSION CRITERIA:\\n\\nThe subjects of this st...  Female   \n",
       "...                                                        ...     ...   \n",
       "NCT05451225  Inclusion Criteria:\\n\\nCorrection Officers;\\no...     All   \n",
       "NCT05489146  Inclusion Criteria:\\n\\nAge 18 or older\\nEpisod...     All   \n",
       "NCT05502081  Inclusion Criteria:\\n\\nage more than 12 years ...     All   \n",
       "NCT05594173  Inclusion Criteria:\\n\\nHealthy adults under ag...     All   \n",
       "NCT05736861  Inclusion Criteria:\\n\\nCompleted Informed Cons...     All   \n",
       "\n",
       "            minimum_age maximum_age  \\\n",
       "nct_id                                \n",
       "NCT00000143    13 Years         NaN   \n",
       "NCT00000378    60 Years    95 Years   \n",
       "NCT00000620    40 Years    79 Years   \n",
       "NCT00001213     2 Years         NaN   \n",
       "NCT00001259    18 Years    45 Years   \n",
       "...                 ...         ...   \n",
       "NCT05451225    21 Years         NaN   \n",
       "NCT05489146    18 Years    80 Years   \n",
       "NCT05502081    12 Years         NaN   \n",
       "NCT05594173    18 Years    60 Years   \n",
       "NCT05736861    30 Years         NaN   \n",
       "\n",
       "                                                    facilities           city  \\\n",
       "nct_id                                                                          \n",
       "NCT00000143            University of South Florida, MDC Box 21          Tampa   \n",
       "NCT00000378                               1051 Riverside Drive       New York   \n",
       "NCT00000620                             Wake Forest University  Winston-Salem   \n",
       "NCT00001213  National Institutes of Health Clinical Center,...       Bethesda   \n",
       "NCT00001259  National Institutes of Health Clinical Center,...       Bethesda   \n",
       "...                                                        ...            ...   \n",
       "NCT05451225                                Columbia University       New York   \n",
       "NCT05489146         Neuromotor Recovery and Rehabilitation Lab     Pittsburgh   \n",
       "NCT05502081                                     El-gomhoria St       Mansoura   \n",
       "NCT05594173  Toronto Rehabilitation Institute - University ...        Toronto   \n",
       "NCT05736861                       Well Pharma Medical Research        Yonkers   \n",
       "\n",
       "                    state      zip        country  \\\n",
       "nct_id                                              \n",
       "NCT00000143         Texas    94143  United States   \n",
       "NCT00000378      New York    10032  United States   \n",
       "NCT00000620    Washington    98195  United States   \n",
       "NCT00001213      Maryland    20892  United States   \n",
       "NCT00001259      Maryland    20892  United States   \n",
       "...                   ...      ...            ...   \n",
       "NCT05451225      New York    10027  United States   \n",
       "NCT05489146  Pennsylvania    15260  United States   \n",
       "NCT05502081    El-dkhalia      050          Egypt   \n",
       "NCT05594173       Ontario  M5G 2A2         Canada   \n",
       "NCT05736861      Virginia    94304  United States   \n",
       "\n",
       "                                           recruitment_details  \\\n",
       "nct_id                                                           \n",
       "NCT00000143                                          June 1997   \n",
       "NCT00000378                                                NaN   \n",
       "NCT00000620  All participants had established type 2 diabet...   \n",
       "NCT00001213                                                NaN   \n",
       "NCT00001259  One participant signed consent but withdrew pr...   \n",
       "...                                                        ...   \n",
       "NCT05451225  Recruitment of the study sample took place in ...   \n",
       "NCT05489146                                                NaN   \n",
       "NCT05502081  from 1/11/2021 to 29/5/2022 at isolation hospi...   \n",
       "NCT05594173                                                NaN   \n",
       "NCT05736861                                                NaN   \n",
       "\n",
       "                                        pre_assignment_details  \\\n",
       "nct_id                                                           \n",
       "NCT00000143                                                NaN   \n",
       "NCT00000378                                                NaN   \n",
       "NCT00000620  Eligible participants provided evidence of abi...   \n",
       "NCT00001213                                                NaN   \n",
       "NCT00001259  8 of 46 participants who completed Study 2, Ph...   \n",
       "...                                                        ...   \n",
       "NCT05451225  Correction officers (COs) were recruited at ea...   \n",
       "NCT05489146                                                NaN   \n",
       "NCT05502081  assignment is applied after admission of parti...   \n",
       "NCT05594173                                                NaN   \n",
       "NCT05736861                                                NaN   \n",
       "\n",
       "                 study_type                                         embeddings  \n",
       "nct_id                                                                          \n",
       "NCT00000143  Interventional  [-0.010117053490566939, 0.0014353180923144734,...  \n",
       "NCT00000378  Interventional  [-0.013839153437317241, -0.003807755615505691,...  \n",
       "NCT00000620  Interventional  [-0.02645666465910675, -0.02204721930749222, 0...  \n",
       "NCT00001213  Interventional  [0.0028949422587708743, -0.016361670996559528,...  \n",
       "NCT00001259  Interventional  [-0.040142119659849006, 0.001966558432531476, ...  \n",
       "...                     ...                                                ...  \n",
       "NCT05451225  Interventional  [-0.02336861067497135, -0.01617507119686338, 0...  \n",
       "NCT05489146  Interventional  [-0.04131284136615776, 0.0042052526653315984, ...  \n",
       "NCT05502081  Interventional  [-0.027679480103407456, 0.011526332956244322, ...  \n",
       "NCT05594173   Observational  [-0.0020168373226194113, 0.01569151381516552, ...  \n",
       "NCT05736861  Interventional  [-0.02718752011814748, 0.0010122289920352244, ...  \n",
       "\n",
       "[28623 rows x 19 columns]"
      ]
     },
     "execution_count": 6,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df = pd.read_csv(\"ctgov_20230613_openai_embedding.csv\", index_col=\"nct_id\")\n",
    "df\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "application/vnd.jupyter.widget-view+json": {
       "model_id": "46e3b217507a4bf5b3628e61c1ee6fca",
       "version_major": 2,
       "version_minor": 0
      },
      "text/plain": [
       "  0%|          | 0/28623 [00:00<?, ?it/s]"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "text/plain": [
       "array([-0.01011705,  0.00143532,  0.01915826, ..., -0.0248823 ,\n",
       "       -0.01993066, -0.02074444], dtype=float32)"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "embeddings = df[\"embeddings\"].copy()\n",
    "embeddings = embeddings.progress_apply(lambda x: np.fromstring(\n",
    "    re.sub(r'[\\n\\[\\]]', '', x), sep=',').astype(np.float32)\n",
    ")\n",
    "embeddings[0]\n"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Write to database"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "documents = df.to_dict(orient=\"records\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [],
   "source": [
    "class Document(Base):\n",
    "    __tablename__ = 'openai'\n",
    "    \n",
    "    nct_id = mapped_column(String, primary_key=True)\n",
    "    brief_title = mapped_column(Text)\n",
    "    official_title = mapped_column(Text)\n",
    "    baseline_measurements = mapped_column(Text)\n",
    "    brief_summaries = mapped_column(Text)\n",
    "    detailed_descriptions = mapped_column(Text)\n",
    "    criteria = mapped_column(Text)\n",
    "    gender = mapped_column(Text)\n",
    "    minimum_age = mapped_column(Text)\n",
    "    maximum_age = mapped_column(Text)\n",
    "    facilities = mapped_column(Text)\n",
    "    city = mapped_column(Text)\n",
    "    state = mapped_column(Text)\n",
    "    zip = mapped_column(Text)\n",
    "    country = mapped_column(Text)\n",
    "    recruitment_details = mapped_column(Text)\n",
    "    pre_assignment_details = mapped_column(Text)\n",
    "    study_type = mapped_column(Text)\n",
    "    embedding = mapped_column(Vector(embeddings[0].shape[0]))\n",
    "\n",
    "\n",
    "Base.metadata.drop_all(engine)\n",
    "Base.metadata.create_all(engine)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {},
   "outputs": [],
   "source": [
    "documents = [\n",
    "    dict(\n",
    "        nct_id=df.index[i],\n",
    "        brief_title=df[\"brief_title\"].iloc[i],\n",
    "        official_title=df[\"official_title\"].iloc[i],\n",
    "        baseline_measurements=df[\"baseline_measurements\"].iloc[i],\n",
    "        brief_summaries=df[\"brief_summaries\"].iloc[i],\n",
    "        detailed_descriptions=df[\"detailed_descriptions\"].iloc[i],\n",
    "        criteria=df[\"criteria\"].iloc[i],\n",
    "        gender=df[\"gender\"].iloc[i],\n",
    "        minimum_age=df[\"minimum_age\"].iloc[i],\n",
    "        maximum_age=df[\"maximum_age\"].iloc[i],\n",
    "        facilities=df[\"facilities\"].iloc[i],\n",
    "        city=df[\"city\"].iloc[i],\n",
    "        state=df[\"state\"].iloc[i],\n",
    "        zip=df[\"zip\"].iloc[i],\n",
    "        country=df[\"country\"].iloc[i],\n",
    "        recruitment_details=df[\"recruitment_details\"].iloc[i],\n",
    "        pre_assignment_details=df[\"pre_assignment_details\"].iloc[i],\n",
    "        study_type=df[\"study_type\"].iloc[i],\n",
    "        embedding=embedding\n",
    "    ) for i, embedding in enumerate(embeddings)\n",
    "]\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {},
   "outputs": [],
   "source": [
    "session = Session(engine)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {},
   "outputs": [],
   "source": [
    "session.execute(insert(Document), documents)\n",
    "session.commit()\n"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Clustering the trials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "2023-06-19 11:10:27.860082: I tensorflow/core/platform/cpu_feature_guard.cc:193] This TensorFlow binary is optimized with oneAPI Deep Neural Network Library (oneDNN) to use the following CPU instructions in performance-critical operations:  AVX2 FMA\n",
      "To enable them in other operations, rebuild TensorFlow with the appropriate compiler flags.\n",
      "2023-06-19 11:10:27.960124: E tensorflow/stream_executor/cuda/cuda_blas.cc:2981] Unable to register cuBLAS factory: Attempting to register factory for plugin cuBLAS when one has already been registered\n",
      "2023-06-19 11:10:28.357297: W tensorflow/stream_executor/platform/default/dso_loader.cc:64] Could not load dynamic library 'libnvinfer.so.7'; dlerror: libnvinfer.so.7: cannot open shared object file: No such file or directory\n",
      "2023-06-19 11:10:28.357340: W tensorflow/stream_executor/platform/default/dso_loader.cc:64] Could not load dynamic library 'libnvinfer_plugin.so.7'; dlerror: libnvinfer_plugin.so.7: cannot open shared object file: No such file or directory\n",
      "2023-06-19 11:10:28.357344: W tensorflow/compiler/tf2tensorrt/utils/py_utils.cc:38] TF-TRT Warning: Cannot dlopen some TensorRT libraries. If you would like to use Nvidia GPU with TensorRT, please make sure the missing libraries mentioned above are installed properly.\n"
     ]
    }
   ],
   "source": [
    "import umap\n",
    "import umap.plot\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(28623, 1536)"
      ]
     },
     "execution_count": 14,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "array = np.stack(embeddings)\n",
    "array.shape\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 15,
   "metadata": {},
   "outputs": [],
   "source": [
    "reduced_embeddings = umap.UMAP().fit(array)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<Axes: >"
      ]
     },
     "execution_count": 16,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "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",
      "text/plain": [
       "<Figure size 576x576 with 1 Axes>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "\n",
    "umap.plot.points(\n",
    "    reduced_embeddings,\n",
    "    labels=df[\"study_type\"], \n",
    "    color_key_cmap='PiYG',\n",
    "    )\n"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Search by trials"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "================================================================================\n",
      "NCT01335932\n",
      "A Randomized Double-Blind Placebo-Controlled Trial of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure (The GRAIL Study)\n",
      "Critical illness due to severe sepsis and trauma are major causes of morbidity and mortality, and a substantial economic burden in the United States and worldwide. Despite advances in clinical care, patients with sepsis and trauma-associated respiratory failure represent specific populations with high rates of adverse outcomes. The etiology of respiratory failure in patients with severe sepsis and trauma is multifactorial, but acute lung injury (ALI) is one of the leading causes, and is associated with prolonged ICU and hospital stays, mortality, and long-term sequelae. Other than general supportive care, few specific interventions other than lung protective ventilation have been shown to improve outcomes in such patients. New approaches for understanding the pathogenesis and developing better therapies are urgently needed.\n",
      "\n",
      "Acute Lung Injury (ALI) is a syndrome consisting of acute hypoxemic respiratory failure with bilateral pulmonary infiltrates that is associated with both pulmonary and nonpulmonary risk factors (eg. sepsis, trauma) and that is not due primarily to left atrial hypertension. Although a distinction between ALI and a more severe subtype (termed acute respiratory distress syndrome (ARDS) has been made, the pathogenesis, risk factors, and outcomes appear to be similar and for the purposes of this protocol, the term acute lung injury [ALI] will be used to encompass both entities. Accepted consensus definitions of ALI have been introduced and are now widely used for laboratory and clinical investigations of ALI. Acute Lung Injury (ALI) is defined as:\n",
      "\n",
      "PaO2/FiO2 <300\n",
      "Bilateral pulmonary infiltrates on chest x-ray\n",
      "Pulmonary Capillary Wedge Pressure <18mmHg or no clinical evidence of increased left atrial pressure Although a broad range of risk factors for ALI have been described, those that account for the majority of cases include: sepsis, pneumonia, trauma, and aspiration. It is well established that severe trauma is recognized as a precipitating cause of ALI. Recent studies have demonstrated that the incidence of acute lung injury (ALI) is much higher than previously thought, with an estimated age-adjusted incidence of 86 per 100,000 persons per year, resulting in an estimated ~190,000 cases annually in the US. The clinical and health care system impact of ALI is substantial, with an estimated 2,154,000 intensive care unit (ICU) days, 3,622,000 hospital days, and 75,000 deaths in 2000, and is expected to grow significantly given the marked age-related incidence and the aging population. Although general improvements in ICU care over the last 2 decades have led to a trend towards lower mortality due to certain ALI-associated risk factors (trauma, aspiration), the most common causes of ALI, sepsis and pneumonia, remain associated with high mortality rates of ~25-35%. Mortality in ALI is most commonly due to secondary infections/sepsis and multiorgan system failure rather than primary respiratory failure due to hypoxemia, highlighting the systemic nature of ALI. Even among initial survivors of ALI, substantial pulmonary and nonpulmonary functional impairment remains for months to years. Specifically, a proportion of those who survive the initial insult are at risk for prolonged mechanical ventilation and ICU/hospital stay, and the risk factors remain poorly defined. It has been hypothesized that a \"2nd hit\" may predispose certain patients to greater morbidity in this setting. Despite intensive basic and clinical investigation, only a single intervention (low-tidal volume [\"lung protective\"] ventilation) is generally accepted to decrease mortality in ALI, while multiple other strategies have failed to improve survival either in early clinical studies or definitive efficacy trials. Thus, given the high incidence and continued substantial clinical impact of ALI despite improvements in general medical/ICU care, and limited proven options other than lung-protective ventilation, new approaches to understanding the pathophysiology and identifying novel targets for intervention in ALI are a high priority.\n",
      "\n",
      "Overly intense, persistent and dysregulated pulmonary and systemic inflammation has emerged as the leading hypothesis for the pathogenesis of ALI and its complications, but the contributory factors and mechanisms are incompletely defined. Several carefully-conducted prospective human studies have shown an association between specific inflammatory biomarkers in blood and BALF (both the initial levels at onset and changes over time) and important clinical outcomes in ALI. [Animal models have also demonstrated an association between inflammatory cytokines and non-pulmonary organ injury and dysfunction] In addition, one of the most important interventions (low-tidal volume [\"lung protective\"] ventilation) shown to decrease mortality in ALI is associated with reductions in inflammatory cytokines (IL-6, IL-8) in blood and bronchoalveolar lavage fluid [BALF].\n",
      "\n",
      "Cytomegalovirus (CMV) is a ubiquitous virus in humans worldwide, and has been linked to adverse clinical outcomes including prolongation of mechanical ventilation, increased length of stay, and mortality in multiple studies of critically-ill, apparently immunocompetent, seropositive adults.\n",
      "\n",
      "Cytomegalovirus (CMV) is a human herpes virus known to infect more than 50-90% of US adults and is known to be a major cause of morbidity and mortality in immunocompromised patients. CMV infection can be acquired through multiple means, including: mother-to-child (in utero, breast milk), infected body fluids (saliva, genital secretions), blood transfusion or organ transplant. The prevalence of CMV infection increases with age throughout life such that by age 90, ~90% of persons will have acquired CMV infection. In immunocompetent persons, following primary infection by any of the routes noted above, CMV is controlled by the immune system and establishes latency (\"dormancy\") in multiple organs/cell-types for the life of the host. In particular, the lung represents one of the largest reservoirs of latent CMV in seropositive hosts, and may explain the propensity for CMV-associated pulmonary disease in predisposed hosts. During periods of immunosuppression (or as a result of specific stimuli such as TNF-Î±, LPS, or catecholamines that are commonly associated with critical illness & sepsis [CMV can reactivate from latency (preferentially in the lung) to produce active infection (viral replication). In persons with impaired cellular immunity, reactivation can progress to high-grade CMV replication and commonly leads to tissue injury and clinically-evident disease such as CMV pneumonia. Lower-grade CMV reactivation that is otherwise clinically silent (\"subclinical\") can also be detected in apparently immunocompetent persons with critical illness using sensitive techniques such as PCR. In addition, even low-level, otherwise asymptomatic subclinical CMV reactivation can produce significant biologic effects both in vitro and in vivo, such as inflammation, fibrosis and immunosuppression. Each of these biologic effects of subclinical CMV infection has either previously been demonstrated (inflammation, fibrosis) or could theoretically be important (immunosuppression) in sepsis-associated ALI and its complications. These biological effects of CMV have been shown to occur through various mediators and other indirect means [Importantly, several important CMV-associated adverse clinical outcomes in transplant populations [allograft rejection, secondary infections] are not necessarily accompanied by overt CMV disease and can only be detected by relatively sensitive means of virus detection such as PCR.\n",
      "\n",
      "Reactivation of CMV in apparently immunocompetent patients with critical illness due to a broad range of causes has been documented in multiple prior studies using a variety of virologic techniques. The specific triggers for CMV reactivation from latency have been identified and are known to be elevated in patients with sepsis and acute lung injury [A prospective study in intubated patients with sepsis from Germany reported more than 60% rate of CMV DNA detection in tracheal aspirates.\n",
      "\n",
      "In addition to CMV reactivation in sepsis, CMV reactivation has also been demonstrated specifically in lung and blood of patients with acute lung injury.\n",
      "\n",
      "Retrospectively testing samples collected in a prospective observational cohort study of patients at risk of developing ARDS, CMV reactivation (ie. CMV DNA by PCR) was detected in BALF and/or plasma of 2/5 [40%] of subjects who developed ARDS, in sequential samples from 7/20 [35%] patients with ARDS, but not in patients at risk but who did not develop ARDS (0/5) [Limaye 2009 unpublished data]. In a separate study, CMV reactivation was retrospectively assessed by PCR in BALF of 88 subjects enrolled in a randomized trial of fish oil for treatment of ALI. Seropositivity at baseline (ie. evidence of latent CMV infection) in the cohort was 65% (similar to prior age-related estimates), and CMV reactivation (ie. CMV DNA by PCR) was detected in BALF of 12/57 [21%] patients [Limaye unpublished data 2009].\n",
      "\n",
      "Several lines of evidence have linked CMV reactivation with adverse clinical outcomes in non-immunosuppressed adults with critical illness. In a recent meta-analysis, CMV reactivation (compared to no reactivation) was associated with a 2-fold increased odds of mortality in ICU patients.\n",
      "\n",
      "In addition to mortality, recent studies have demonstrated a strong and independent association between CMV reactivation and increased hospital and ICU length of stay and duration of mechanical ventilation.\n",
      "================================================================================\n",
      "NCT01602614\n",
      "Evaluation of the Pharmacokinetics and Pharmacodynamics of Ganciclovir in Premature Infants Receiving Treatment for Cytomegalovirus Infection\n",
      "This is an open-label, multi-center, clinical sampling study to assess ganciclovir pharmacokinetics and pharmacodynamics in premature infants. Only those subjects who receive ganciclovir for clinical reasons will be enrolled. The decision to initiate ganciclovir therapy will be made by the attending physician based upon his/her clinical decision to treat virologically-confirmed CMV infection; infants receiving such therapy and meeting entry criteria will then be eligible for this study. Therefore, ganciclovir will not provided under this protocol.\n",
      "\n",
      "Subjects meeting enrollment criteria will be entered into this clinical trial. Subjects will be stratified by gestational age and by chronologic age as follows: 1) â‰¤ 27 weeks 6 days gestational age at birth and â‰¤ 30 days chronologic age at study enrollment; 2) â‰¤ 27 weeks 6 days gestational age at birth and > 30 days chronologic age at study enrollment; 3) â‰¥ 28 weeks 0 days gestational age at birth and â‰¤ 30 days chronologic age at study enrollment; 4) â‰¥ 28 weeks 0 days gestational age at birth and > 30 days chronologic age at study enrollment. Eight subjects will enroll in each of the four groups, for a total sample size of 32 subjects. Subjects in each cohort with inadequate pharmacokinetic data for analysis (e.g., due to dropping out of the study before PK assessments are performed, or blood sampling obtained but is inadequate for analysis) will be replaced and will not count toward the total of eight subjects in each of the four groups. Additionally, enrollment of an additional 2-3 subjects may be allowed for operational reasons.\n",
      "\n",
      "A full pharmacokinetic profile will be obtained with one of the ganciclovir doses received after enrollment. PK assessments will be obtained after the subject has received study assessment dose 3, 4, 5, 6, 7, or 8 of intravenous ganciclovir. Specimens will be shipped for processing at that time. The pharmacokinetic data will then be provided to the study site, including the area under curve (AUC) and clearance (CL) values for information purposes.\n",
      "\n",
      "Duration of intravenous ganciclovir therapy is at the discretion of the treating physician and will not be dictated by the research protocol. Both whole blood for CMV polymerase chain reaction (PCR) and urine for CMV detection will be obtained once in each study period as long as the subject is receiving intravenous ganciclovir therapy. These specimens will be used to determine blood viral load and ganciclovir resistance. Since ganciclovir is a renally excreted drug, serum creatinine will be drawn for the research protocol on the day that the ganciclovir pharmacokinetic specimens are obtained in order to calculate creatinine clearance using a method such as the modified Schwartz formula, and thus correlate ganciclovir clearance with renal function. Otherwise, data from hematology assessments (WBC count and differential, hemoglobin, platelet count) and from chemistry labs (serum creatinine, aspartate aminotransferase (AST) , and alanine aminotransferase (ALT) will be recorded on the study case report forms during each study period if they are being obtained for clinical reasons, but will not be drawn only for the purposes of the study. Ganciclovir dosing information (mg/dose, dosing interval, and patient weight) will be recorded on the day of the pharmacokinetic blood draws, and weekly from Period 1 through Period 7 as long as the subject is receiving intravenous ganciclovir therapy.\n",
      "\n",
      "If the patient continues to receive intravenous ganciclovir from Study Assessment Day 18 through Study Assessment Day 24 (Period 4), a second PK assessment may be performed at the request of the treating physician if the subject weighs 575 grams or more at the time of specimen collection.\n",
      "================================================================================\n",
      "NCT00530218\n",
      "Phase II Study of Intravenous Ganciclovir Followed by Oral Ganciclovir in the Treatment of Reactivation of CMV Following Bone Marrow Transplant\n",
      "OBJECTIVES:\n",
      "\n",
      "To determine the feasibility of using oral ganciclovir (GCV) following induction with intravenous GCV in the setting of cytomegalovirus (CMV) reactivation after bone marrow transplantation.\n",
      "\n",
      "OUTLINE: Blood cultures for cytomegalovirus (CMV) are obtained periodically after the planned bone marrow transplantation (BMT). Patients showing reactivation of CMV receive induction ganciclovir (GCV) IV twice a day on days 1-7. Patients then receive maintenance oral GCV three times a day for 5 weeks in the absence of disease progression or unacceptable toxicity.\n",
      "\n",
      "Patients undergo blood collection periodically during study for pharmacokinetic studies.\n",
      "================================================================================\n",
      "NCT01769170\n",
      "A Phase 3 Study of the Safety, Tolerability, and Efficacy of CMX001 for the Prevention of Cytomegalovirus (CMV) Infection in CMV-seropositive (R+) Hematopoietic Stem Cell Transplant Recipients\n",
      "This was a randomized, double-blind, placebo-controlled, parallel group multicenter study of oral brincidofovir (BCV) in approximately 450 cytomegalovirus (CMV)-seropositive subjects who had undergone allogeneic hematopoietic stem cell transplantation (HCT). The study consisted of a screening evaluation and a treatment phase of 10 to 14 weeks. Dosing with the study drug (BCV or placebo) was initiated as soon as individual subjects could ingest tablets after transplant but no later than Day 28 post-transplant, and was continued through Week 14. All randomized subjects remained on study and followed the same scheduled study treatment. Study assessments were performed weekly from randomization through completion of the first post-treatment follow-up assessment at Week 15, and every 3 weeks thereafter through Week 24.\n",
      "================================================================================\n",
      "NCT00942305\n",
      "A Multicenter, Randomized, Double-blind, Placebo-controlled, Dose-escalation Study of the Safety, Tolerability and Ability of CMX001 to Prevent or Control CMV Infection in R+ Hematopoietic Stem Cell Transplant Recipients\n",
      "This was to be a 2-part study. Part 1 was a randomized, double-blind, placebo-controlled, dose-escalation study of multiple doses of oral brincidofovir (BCV) in R+ hematopoietic stem cell transplant (HCT) recipients. In Part 2, one of the dose levels administered in Part 1 was to be tested against placebo to evaluate the statistical significance of BCV as a therapy for preventing progression of cytomegalovirus (CMV) infection or preventing CMV disease. The first 3 dose-escalating cohorts in Part 1 were to include 32 subjects within each cohort (24 randomized to receive oral BCV and 8 randomized to receive placebo in a 3:1 ratio) for a total of 96 planned subjects. Following completion of the first 3 cohorts and subsequent safety review of the data, up to an additional 3 cohorts of 32 subjects each could have been enrolled. Two additional cohorts (labeled Cohort 4 and Cohort 4A) beyond the initial 3 cohorts were actually enrolled in Part 1 of the study. Following the safety and antiviral activity analyses of the 5 cohorts in Part 1 and the number of subjects enrolled in each of those cohorts, Part 2 of the study was not conducted.\n"
     ]
    }
   ],
   "source": [
    "doc = session.get(Document, \"NCT00000143\")\n",
    "neighbors = session.scalars(\n",
    "    select(Document)\n",
    "    .filter(Document.nct_id != doc.nct_id)\n",
    "    .order_by(Document.embedding.cosine_distance(doc.embedding))\n",
    "    .limit(5))\n",
    "for neighbor in neighbors:\n",
    "    print(\"=\"*80)\n",
    "    print(neighbor.nct_id)\n",
    "    print(neighbor.official_title)\n",
    "    print(neighbor.detailed_descriptions)\n",
    "    # print(neighbor.criteria)\n"
   ]
  },
  {
   "attachments": {},
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Search by query"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {},
   "outputs": [],
   "source": [
    "from scipy import spatial\n",
    "import time\n",
    "from langchain.embeddings import OpenAIEmbeddings\n",
    "\n",
    "\n",
    "model = OpenAIEmbeddings(openai_api_key=OPENAI_API_KEY)\n",
    "\n",
    "def cosine_similarity(a, b):\n",
    "    return 1 - spatial.distance.cosine(a, b)\n",
    "\n",
    "\n",
    "def _generate_embedding(\n",
    "    text=None,\n",
    "    model=None,\n",
    "    amount=0,\n",
    "):\n",
    "    assert model is not None\n",
    "    embedding = model.embed_documents([text])\n",
    "    time.sleep(amount)\n",
    "    embedding = np.array(embedding).squeeze()\n",
    "    return embedding"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1536\n",
      "================================================================================\n",
      "NCT01733628\n",
      "Evaluation Study of Hypertension as a Predictor of Efficacy Bevacizumab (BV) in Combination With Chemotherapy (CT) in Metastatic Colorectal Cancer (MCC) and Metastatic Breast Cancer (MBC).\n",
      "Hypertension (HT) is the most common side effect seen in trials of bevacizumab in combination with chemotherapy. Based on the hypothesis that the development of hypertension during treatment would be an indicative of the successful blockade of the Vascular Endothelial Growth Factor (VEGF) pathway, different studies have explored retrospectively the relationship between hypertension and the results of treatment with bevacizumab.\n",
      "\n",
      "This study aims to demonstrate the association between hypertension (diagnosed optimally) with efficacy to treatment with bevacizumab prospectively and secondly verify if blood pressure measures taken at home are a reflection of a diagnosis of hypertension.\n",
      "\n",
      "Also have been explored different molecular markers involved in the pathway of VEGF which might be used as predictors of response. Therefore, this study includes the collection of blood samples (serum or plasma) and tumor tissue of patients included in this study, with the aim of exploring biomarkers that correlate with treatment efficacy and toxicity.\n",
      "\n",
      "The diagnosis of hypertension (HT) will be performed using a Holter recording, and standard blood pressure footage will be collected during the first three cycles of treatment given the Common Toxicity Criteria of the National Cancer Institute-NCI CTCAE version 4.0 and the guidelines of the European Society of Cardiology and Hypertension, 2007.\n",
      "\n",
      "Will be collected a sample of primary tumor and blood for patients who previously have consented it. Samples will be sent to a central laboratory for analysis of biomarkers.\n",
      "\n",
      "An interim analysis will be conducted to assess the true incidence of hypertension. Based on this analysis, will be evaluated the need to recalculate the sample size.\n",
      "\n",
      "At the end of the study, will be performed an analysis of correlation of data measured by standard BP (Blood Pressure) and Holter recording footage with the PFS. Moreover will be determined in serum, plasma and tumor tissue and certain biomarkers to correlate with efficacy to treatment with bevacizumab.\n",
      "================================================================================\n",
      "NCT03123263\n",
      "Echocardiographic Changes During Adjuvant Therapy in Hispanic Women With Her-2 Neu Expressing Breast Cancer\n",
      "Transtuzumab based chemo-immunotherapy is commonly administered to patients diagnosed with early stage HER-2 expressing breast cancer, because it decreases the risk of relapse.\n",
      "\n",
      "Transtuzumab affects cardiac function and potential benefits in decreasing cancer recurrence have to be balanced against short and long term toxicity.\n",
      "\n",
      "We have previously identified a high prevalence of metabolic syndrome and type II diabetes mellitus in our patients with breast cancer. These patients may be particularly susceptible to cardiotoxic effects of transtuzumab based therapy.\n",
      "\n",
      "Aim of this study is to assess the changes in the cardiac function of women who are undergoing transtuzumab based therapy for early stage breast cancer.\n",
      "================================================================================\n",
      "NCT01847001\n",
      "A Study of the Beta-blocker Propranolol Alone and With Chemotherapy in Patients Receiving Neoadjuvant Treatment for Newly Diagnosed Breast Cancer\n",
      "While a number of therapeutic options exist for patients with breast cancer (BC), breast tumor biology is differs across tumors and not all BCs respond to treatment. Identifying a marker predicting response could spare non-responders unnecessary side effects, cost, and time. A recent example in BC is bevacizumab, an expensive anti-angiogenic monoclonal antibody, for which the FDA revoked approval for patients with metastatic BC. While this targeted therapy may benefit some patients, no appropriate predictive marker has been identified in the drug development process. An ideal biologic marker would be easy to perform, reliable, low-cost and non-invasive. A limitation of assessing tumor-based markers in metastatic BC is the inability to procure tumor tissue at different treatment times. To circumvent this issue, anti-cancer agents can be assessed pre-operatively, where women with newly diagnosed BC receive a study drug, alone or with chemotherapy, between diagnostic breast biopsy and surgical resection. In addition, tumor changes can be directly compared to modulation of non-invasive markers, such as functional radiographs or blood, to identify a non-invasive marker predicting tumor response.\n",
      "\n",
      "The investigators are conducting a neoadjuvant single-institution trial with the non-selective, inexpensive Î² -blocker propranolol with chemotherapy in locally advanced BC. Î²-blockade regulates angiogenesis in primary breast tumors. In these trials, the investigators plan to evaluate treatment-related microvascular response via changes in breast Diffuse Optical Tomography (DOT), a non-invasive, fast, safe, and inexpensive breast imaging tool. As the optical property contrast from endogenous chromophores (oxyhemoglobin, deoxyhemoglobin, water, and lipid) provides information on tissue vascularity, it can monitor response to anti-angiogenic agents. DOT changes occur as early as 1 week after starting pre-operative therapy. The dynamic DOT system incorporated in these trials is unique to Columbia University Medical Center (CUMC), as it has been designed by Columbia biomedical engineers. CUMC's laboratory collaborators have measured this DOT system with anti-angiogenesis agents in animal models, demonstrating the translational nature of this project. While non-dynamic DOT has been assessed in other neoadjuvant trials with small cohorts receiving heterogeneous chemotherapy agents, none have evaluated DOT response to anti-angiogenic agents.\n",
      "================================================================================\n",
      "NCT01063283\n",
      "A Randomized, Open-Label, Dose Escalation Study of Bevacizumab With Ambulatory Blood Pressure Monitoring in Previously Untreated Patients With Advanced Non-squamous Non-Small Cell Lung Cancer\n",
      "Carboplatin and pemetrexed are FDA approved chemotherapy agents for patients with advanced non squamous non small cell lung cancer. Bevacizumab is also FDA approved in lung cancer , and the combination of all three drugs is promising. The doctors directing this research want to learn how to better personalize drug dosing of bevacizumab by identifying people who could safely take a higher dose of the drug.\n",
      "================================================================================\n",
      "NCT00781365\n",
      "Home Blood Pressure Telemonitoring and Case Management to Control Hypertension\n",
      "Blood pressure (BP) is controlled to recommended levels in only 1 in 3 people with hypertension, and there has been little improvement since the late 1980s, despite advances in evidence to support aggressive hypertension control, and availability of many new and effective antihypertensive drugs. It is clear that meaningful and sustained improvement in hypertension control will likely require fundamental changes in the current physician-centered office-visit based model of caring for hypertension. In this project we develop and implement an intervention that takes advantage of new technology and team models of care to improve BP measurement and control, solving the problems that have limited the application of case management approaches to hypertension care improvement. The study will take place in a diverse population of adults with hypertension cared for in a real-world primary care setting. The Telemonitoring Intervention (TI) integrates 2 innovative components: First, home BP measures are done using state-of-the-art modem-enabled automated equipment that internally stores and electronically transmits BP data through a simple touch-tone telephone connection to a secure web site. Second, a pharmacist case manager integrated with the primary care team through a jointly used electronic medical record (EMR) and formulary adjusts antihypertensive therapy using an approved written protocol, under a collaborative practice agreement with physicians. Treatment decisions are based on home BP data and are discussed and communicated to patients in telephone visits with the pharmacist case manager. Two-way communication between the pharmacist case manager and the patient's primary care team is assured by using a shared EMR and by additional secure messaging of the results of every pharmacist encounter to the primary care team. To assess the impact of the TI on hypertension control, patient satisfaction, and costs of care, we will conduct a cluster-randomized trial, assigning 16 primary care clinics and 450 of their nested patients with uncontrolled hypertension to either a Usual Care (UC) control group or TI. Blood pressure outcomes in both groups will be determined at baseline, 6, 12, 18 and 54 months in an identical and blinded fashion in a research clinic separate from the clinical setting where patients received their medical care. We hypothesize that guideline BP control will be achieved at 6 months and maintained at 12 months in more than 60% of patients from TI clinics, compared to < 40% in patients from UC clinics. We will compare satisfaction with care and costs in the TI and UC groups. The TI has the potential to improve hypertension control for millions of patients, and could be implemented widely in diverse and large patient populations based on performance in this randomized trial. The results of the project will have important implications for future efforts to improve care provided to many of the estimated 20 million Americans with uncontrolled hypertension.\n"
     ]
    }
   ],
   "source": [
    "query = \"HyperTension with Breast Cancer\"\n",
    "\n",
    "qry_embeddding = _generate_embedding(query, model=model)\n",
    "\n",
    "print(len(qry_embeddding))\n",
    "neighbors = session.scalars(\n",
    "    select(Document)\n",
    "    # l2 distance\n",
    "    .order_by(Document.embedding.cosine_distance(qry_embeddding.tolist()))\n",
    "    .limit(5))\n",
    "for neighbor in neighbors:\n",
    "    print(\"=\"*80)\n",
    "    print(neighbor.nct_id)\n",
    "    print(neighbor.official_title)\n",
    "    print(neighbor.detailed_descriptions)\n",
    "    # print(neighbor.criteria)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1536\n",
      "================================================================================\n",
      "NCT01127659\n",
      "Effect of Hypogonadotrophic Hypogonadism and Treatment With Testosterone on Insulin Sensitivity, Inflammation, Body Composition and Sexual Function in Obese and Type 2 Diabetic Men\n",
      "Hypogonadotropic hypogonadism (HH) occurs in approximately one-third of obese and type 2 diabetic men. Considering that there are 24 million diabetic and 100 million obese people, of which half are males, obesity and type 2 diabetes potentially constitute the major cause of hypogonadism in the population. We hypothesize that 1) HH in obese and type 2 diabetic men is associated with decreased insulin sensitivity, increased fat tissue mass, decreased lean body mass, increased inflammatory and oxidative stress, impaired sexual function and depressed mood as compared to diabetic and obese men with normal testosterone concentrations; and that 2) testosterone replacement for 24 weeks in men with HH leads to an improvement in these parameters. Our proposed study would be the first prospective, randomized trial to comprehensively evaluate the effect of HH on insulin sensitivity, body composition, inflammatory and oxidative indices in obese and type 2 diabetic subjects and the effect of six months of T replacement on these parameters. The study will have 2 arms (obese and type 2 diabetic arm) with 120 subjects in Diabetes arm and 80 subjects in obese arm. Half of men in each arm will have HH and half men will have normal testosterone concentrations(eugonadal men). Insulin sensitivity will be assessed by hyperinsulinemic-euglycemic clamps. Subcutaneous fat mass and lean body mass will be measured by DEXA and intra-abdominal (visceral) fat mass by MRI. All subjects will undergo hyperinsulinemic-euglycemic clamp, MRI, DEXA and give blood and urine samples (for measurement of inflammatory and oxidative stress) at baseline. Men with HH will then be randomized to receive testosterone or placebo gel for a total of 24 weeks. These men will undergo hyperinsulinemic-euglycemic clamps and give blood and urine samples for inflammation and oxidative stress at 4 weeks and 24 weeks. MRI and DEXA examinations will be carried out at 24 weeks again in men with HH. The primary endpoint of the study is to define a difference in whole body glucose uptake during hyperinsulinemic-euglycemic clamps between hypogonadal and eugonadal diabetes patients at baseline and an increase in glucose uptake in HH subjects after treatment with testosterone for 24 weeks. 30 subjects per group(testosterone and placebo gel each) will provide adequate power (0.8) to detect a significant difference of 10% in whole body glucose uptake. Therefore there will be 60 men with HH in each arm in diabetes group. For baseline comparisons, 60 men with normal testosterone concentrations will also be needed in each arm. We will recruit 40 obese patients in each arm. Thus there will be 120 diabetic men and 80 obese men in the study.\n",
      "================================================================================\n",
      "NCT00504712\n",
      "A Randomised, Double Blind, Placebo Controlled, Parallel Pilot Study to Test the Effect of Testosterone Treatment on Peripheral Vascular Disease in Hypogonadal Men With Type 2 Diabetes Mellitus\n",
      "Testosterone treatment has shown beneficial effects on blood sugar control and obesity in pilot studies in men with type 2 diabetes. Beneficial effects have also been seen on angina- a disease related to atherosclerosis (narrowing of the arterial blood vessels). Peripheral vascular disease is also caused by atherosclerosis. We hypothesise that testosterone will have beneficial effects on peripheral vascualr disease in men with low serum testosterone and type 2 diabetes.\n",
      "================================================================================\n",
      "NCT02555631\n",
      "Translating the Diabetes Prevention Program to Engage Men From Disadvantaged Areas\n",
      "During year one, the multi-disciplinary research team will work closely with the expert and community Advisory Panel and consultants to adapt the standard NDPP curriculum in order to promote increased engagement of men. \"Engagement\" is defined in this proposal to include recruitment, group participation and retention in the 16-week program. This modified NDPPâ™‚ (i.e., for men) renamed by the advisory panel as \"Power Up for Health,\" will have only NDPP-trained male coaches and male participants, with adaptations to dietary and physical activity messaging and a new behavioral \"toolbox\" approach developed for men.\n",
      "\n",
      "By month 10 of year one, investigators will begin implementation of the 16-week pilot studies of the NDPPâ™‚ at 6 NYC Parks and Recreation Department (REC) sites in disadvantaged communities in three of the NYC boroughs currently offering the standard NDPP programming. Investigators will utilize an iterative and adaptive process during the pilot phase to modify recruitment and retention strategies, as well as the NDPP curriculum and activities. The exploratory aim, as feasible, is to then compare the adapted NDPPâ™‚ pilot data to the standard NDPP mixed-gender groups' available data on recruitment, participation, weight loss, and retention of men from similar NYC neighborhoods. The goal will be pilot study data from 15-20 male participants at each REC pilot site-a recruitment goal of 120 male participants. Working in collaboration with the investigators' consultants and Advisory Panel of community leaders and academic experts in men's health promotion, as well as study partners at the NYC Department of Parks and Recreation, investigators will conduct focused outreach to the target populations.\n",
      "\n",
      "The Specific Aims for the Pilot Study are:\n",
      "\n",
      "Aim 1. to collaborate with the expert and community Advisory Panel to complete the adaptation of the NDPP curriculum and the recruitment and retention activities to better engage men with prediabetes from disadvantaged communities of NYC;\n",
      "\n",
      "Aim 2. to assess preliminary indicators of effectiveness of the NDPPâ™‚ with respect to reductions in body weight; Hypothesis 1: Men engaged in the NDPPâ™‚ will have reductions in body weight at 16 weeks at least equivalent to the NDPP goal of 5-7% of their baseline body weight.\n",
      "\n",
      "Aim 3. to examine and describe from pilot data the extent to which recruitment, intervention and retention strategies, tailored for men with prediabetes are associated with improved engagement of the target population; Exploratory Hypothesis 3.1: Recruitment of men to NDPPâ™‚ will occur more rapidly and with less intensive strategies than recruitment of men to the standard NDPP in comparable communities.\n",
      "\n",
      "Exploratory Hypothesis 3.2: Men enrolled in the NDPPâ™‚ will be more engaged in program activities and self-report greater improvements in healthy eating and physical activity compared with men in the standard NDPP.\n",
      "\n",
      "Exploratory Hypothesis 3.3: Men enrolled in the NDPPâ™‚ will have retention rates that are at least equivalent to men in the standard NDPP.\n",
      "\n",
      "All comparison data analyses are exploratory and as data are available.\n",
      "\n",
      "Aim 4. to examine preliminary data to identify demographic, psychosocial, neighborhood, and REC site characteristics associated with differential recruitment, retention and intervention effects in the NDPPâ™‚.\n",
      "================================================================================\n",
      "NCT01375660\n",
      "Vitamin D Deficiency and Treatment in Male Veterans at Risk for Diabetes\n",
      "The goal of this randomized clinical trial (RCT) is to determine vitamin D efficacy and safety for improving early markers of T2DM in African American male (AAM) veterans at risk for T2DM (n=205, duration 12 months).\n",
      "\n",
      "The primary outcome will be change in oral glucose insulin sensitivity (OGIS). The secondary outcomes will include various parameters of glucose metabolism and other biomarkers.\n",
      "\n",
      "Analysis based on primary and secondary goal as well as predetermined levels of A1C, OGTT and 25OHD at the end of the study.\n",
      "================================================================================\n",
      "NCT00123110\n",
      "Insulin Resistance and Testosterone in Non-Diabetic Postmenopausal Women\n",
      "This study tests the central hypothesis that insulin resistance (IR) increases androgen (male sex hormone) production in postmenopausal women. Participation will include five visits, each lasting on average 2.5 hours, over a period of 13-20 weeks.\n",
      "\n",
      "At the screening visit, the participant's medical history, current use of medications and dietary supplements, and social habits will be recorded. This information will be reviewed on each subsequent visit; participants are asked to maintain their current diet and physical activity level throughout the study.\n",
      "\n",
      "A brief physical exam will be performed, and blood will be drawn.\n",
      "\n",
      "At the 2nd (baseline) visit, patients will undergo a euglycemic-hyperinsulinemic clamp (a procedure to measure insulin sensitivity by continuous intravenous infusion of insulin, and variable infusion of glucose). Blood samples will be drawn throughout the procedure. At completion, the insulin infusion will be stopped, participants will be fed, and the glucose infusion continued for at least 15 minutes to ensure stability of the blood glucose concentration. After the procedure, participants will be randomized to receive either metformin plus leuprolide placebo, leuprolide plus metformin placebo, or metformin placebo plus leuprolide placebo. The leuprolide or leuprolide placebo will be administered as an injection by a nurse. The metformin or metformin placebo will be dispensed to the participant in the form of pills, with instructions for titrating the dose. Participants will be contacted by telephone once weekly during the titration period to assess drug tolerability and adverse events (AEs). Participants will be maintained at their maximum tolerated dose for the duration of the study intervention period.\n",
      "\n",
      "Participants will return every 4 weeks for follow-up. Blood will be drawn, the nurse will administer the leuprolide or leuprolide placebo injection, and metformin or metformin placebo will be dispensed. At the final visit (week 12), participants will undergo a brief physical exam, and will then undergo a final euglycemic-hyperinsulinemic clamp.\n"
     ]
    }
   ],
   "source": [
    "query = \"Diabetes for men\"\n",
    "\n",
    "qry_embeddding = _generate_embedding(query, model=model)\n",
    "\n",
    "print(len(qry_embeddding))\n",
    "neighbors = session.scalars(\n",
    "    select(Document)\n",
    "    # l2 distance\n",
    "    .order_by(Document.embedding.cosine_distance(qry_embeddding.tolist()))\n",
    "    .limit(5))\n",
    "for neighbor in neighbors:\n",
    "    print(\"=\"*80)\n",
    "    print(neighbor.nct_id)\n",
    "    print(neighbor.official_title)\n",
    "    print(neighbor.detailed_descriptions)\n",
    "    # print(neighbor.criteria)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "medqa",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.8.13"
  },
  "orig_nbformat": 4
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
